Synapsoft logo
AI Insights from Disclosures
Searching...
GeneOne Life Science, Inc. 011000
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
GeneOne Life Science, Inc. engages in the biopharmaceuticals business, which is divided into (1) the biopharmaceuticals CDMO business and the next-generation bio new drug development business. The biopharmaceuticals CDMO business produces cGMP-grade plasmid DNA products, raw materials for gene therapies and DNA vaccines required for clinical and non-clinical trials, at VGXI, Inc., a local subsidiary established in the United States in June 2008, and sells them through its overseas sales branch, VGXI USA.
Representative Director 김경진(단독대표)
Founded January 27, 1976
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-0191562
Business number 120-81-14898
Phone Number 02-6949-4056
Fax Number 02-557-6784
Website www.genels.com
Company Address 5 Digital-ro 26-gil, Guro-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant